<code id='7AA6274DA3'></code><style id='7AA6274DA3'></style>
      • <acronym id='7AA6274DA3'></acronym>
      <center id='7AA6274DA3'><center id='7AA6274DA3'><tfoot id='7AA6274DA3'></tfoot></center><abbr id='7AA6274DA3'><dir id='7AA6274DA3'><tfoot id='7AA6274DA3'></tfoot><noframes id='7AA6274DA3'>
      • <optgroup id='7AA6274DA3'><strike id='7AA6274DA3'><sup id='7AA6274DA3'></sup></strike><code id='7AA6274DA3'></code></optgroup>
        5. <b id='7AA6274DA3'><label id='7AA6274DA3'><select id='7AA6274DA3'><dt id='7AA6274DA3'><span id='7AA6274DA3'></span></dt></select></label></b><u id='7AA6274DA3'></u>
          <i id='7AA6274DA3'><strike id='7AA6274DA3'><tt id='7AA6274DA3'><pre id='7AA6274DA3'></pre></tt></strike></i>
           
   
   
   
 

  
           
   
           
    
           
     
          
       Home / fashion / knowledge      
           
     
           
      
          knowledge 
           
      
           
      
           
       2025-09-29 01:02:24 
   
      
           
      
           
                        
          knowledge  
          
                                   
                 
                                      author：explore   
                                        
                                      
                                      Page View：8948
                                  
                                    
          
                                   
          Editor’s note: A recording of the event is embedded below.
          After a few go-go years, the early-stage biotech market has cooled considerably. Two VCs will weigh in on what distinguishes great science from bad investments.
          advertisement
          Featured Speakers
          • Irena Melnikova, Ph.D., partner, Pfizer Ventures
          • Rakhshita Dhar, senior director, venture investments, Leaps by Bayer
          • Frank S. David, M.D., Ph.D., managing director, Pharmagellan (moderator)
          Get unlimited access to award-winning journalism and exclusive events.					
          Subscribe																						Log In															
                      
                              
          
                                 Previous article：

                                
                                          Judge in Trump's Jan. 6 case gives attorneys 2 weeks to propose trial date
                                
                            
          Next article：  
                                      
                                          DIEP, the 'gold standard' of breast reconstruction, is under threat
                                                                    
          

      
           
    


       
       
       
    
     
           
    
           
    
           
   
      
     
           
      
           
       
          Related articles